cocktail

Ground Report | New Delhi: Roche India and Cipla announced the launch of their antibody cocktail – ‘Casirivimab and Imdevimab’ for the treatment of mildly infected patients of Covid-19 in India. The first batch of antibody cocktail is made available in India and is priced at Rs 59,750 per dose. At the same time another batch will … Read more